AstraZeneca Shots Have Good Risk-Benefit Profile for Over 60s, Says EMA Official
MILAN (Reuters) -The head of the EU drug regulator's COVID-19 task force said on Sunday that AstraZeneca's coronavirus vaccine had a favourable …
Neelum Ahluwalia flipped this story into A to Z•1038d
Related storyboards
More stories from AstraZeneca
- dwberkflipped into Money Money Money
4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
It's been quite the journey for the investment community since this decade began. After four consecutive years of the major stock indexes trading off …
- InvestorPlaceflipped into InvestorPlace
3 Pharma Stocks That Are Money-Printing Machines in 2024
The future of the U.S. economy appears promising, with robust growth and strong corporate performance. This economic strength has propelled the stock …
- The Evening Standardflipped into News | Evening Standard
Baroness Chakrabarti scolded by Lords leader after shouting at health minister
A Labour peer has been scolded by the Leader of the House of Lords after she lost her temper and shouted at a health minister. Baroness Chakrabarti, …
Join the flipboard community
Discover, collect, and share stories for all your interests
Sign upMore stories from COVID-19 Vaccines
People Are Questioning Travis Kelce After He "Liked" Instagram Photos With Donald Trump At A Sporting Event
The post includes Trump smiling, shaking hands, and watching UFC. Travis Kelce is garnering attention for "liking" an Instagram post heavily featuring Donald Trump at a UFC event. The Kansas City star has never publicly stated a political party affiliation. He has previously advocated for stricter …
- Dawn Martinflipped into Read NOW
Chrystia Freeland kills COVID-19 income supports and announces replacements
Welcome to a sneak peek of the Maclean’s Politics Insider newsletter. Sign up to get it delivered straight to your inbox in the morning. Existing …
- dwberkflipped into US President
Vaccine Breakthrough Means No More Chasing Strains
Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely …